These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 8538848

  • 1. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
    Jespersen B, Eiskjaer H, Mogensen CE, Sørensen SS, Pedersen EB.
    Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
    [Abstract] [Full Text] [Related]

  • 2. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
    Jespersen B, Eiskjaer H, Jensen JD, Mogensen CE, Sørensen SS, Pedersen EB.
    Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729
    [Abstract] [Full Text] [Related]

  • 3. Effect of frusemide on atrial natriuretic peptide, guanosine cyclic monophosphate, angiotensin II, aldosterone, vasopressin, prostaglandin E2 and blood volume in the nephrotic syndrome.
    Jespersen B, Sørensen SS, Pedersen EB.
    Nephrol Dial Transplant; 1991 Jul; 6(6):402-9. PubMed ID: 1652115
    [Abstract] [Full Text] [Related]

  • 4. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B.
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [Abstract] [Full Text] [Related]

  • 5. Dose-response study of atrial natriuretic peptide bolus injection in healthy man.
    Eiskjaer H, Pedersen EB.
    Eur J Clin Invest; 1993 Jan; 23(1):37-45. PubMed ID: 8383057
    [Abstract] [Full Text] [Related]

  • 6. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
    Eiskjaer H, Schmiegelow M, Jespersen B, Tietze IN, Jensen JD, Sørensen SS, Thomsen K, Pedersen EB.
    Eur J Clin Pharmacol; 1991 Jan; 41(6):547-54. PubMed ID: 1840038
    [Abstract] [Full Text] [Related]

  • 7. Renal and hormonal actions of atrial natriuretic peptide during angiotensin II or noradrenaline infusion in man.
    Eiskjaer H, Nielsen CB, Sørensen SS, Pedersen EB.
    Eur J Clin Invest; 1996 Jul; 26(7):584-95. PubMed ID: 8864421
    [Abstract] [Full Text] [Related]

  • 8. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
    Plum J, Mirzaian Y, Grabensee B.
    Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
    [Abstract] [Full Text] [Related]

  • 9. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.
    Eiskjaer H, Nielsen CB, Pedersen EB.
    J Intern Med; 1994 Dec; 236(6):665-74. PubMed ID: 7989902
    [Abstract] [Full Text] [Related]

  • 10. Change in renal tubular sodium and water handling during progression of polycystic kidney disease: relationship to atrial natriuretic peptide.
    Sørensen SS, Glud TK, Sørensen PJ, Amdisen A, Pedersen EB.
    Nephrol Dial Transplant; 1990 Dec; 5(4):247-57. PubMed ID: 2141389
    [Abstract] [Full Text] [Related]

  • 11. Atrial natriuretic peptide and blood volume in patients with chronic glomerulonephritis: effects of albumin and frusemide administration.
    Jespersen B, Danielsen H, Pedersen EB.
    Nephrol Dial Transplant; 1990 Dec; 5(12):997-1006. PubMed ID: 1965738
    [Abstract] [Full Text] [Related]

  • 12. Abnormal distal tubular sodium reabsorption during dopamine infusion in patients with essential hypertension evaluated by the lithium clearance methods.
    Nielsen CB, Pedersen EB.
    Clin Nephrol; 1997 May; 47(5):304-9. PubMed ID: 9181277
    [Abstract] [Full Text] [Related]

  • 13. Effect of pinacidil on renal haemodynamics, tubular function and plasma levels of angiotensin II, aldosterone and atrial natriuretic peptide in healthy man.
    Nielsen CB, Pedersen EB.
    Eur J Clin Pharmacol; 1993 May; 45(1):29-35. PubMed ID: 8405026
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
    Eiskjaer H, Bagger JP, Danielsen H, Jensen JD, Jespersen B, Thomsen K, Sørensen SS, Pedersen EB.
    Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
    [Abstract] [Full Text] [Related]

  • 15. Atrial natriuretic peptide and exaggerated natriuresis during acute hypertonic volume expansion in essential hypertension.
    Sørensen SS, Danielsen H, Amdisen A, Pedersen EB.
    J Hypertens; 1989 Jan; 7(1):21-9. PubMed ID: 2523419
    [Abstract] [Full Text] [Related]

  • 16. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H, Nielsen CB, Pedersen EB.
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [Abstract] [Full Text] [Related]

  • 17. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
    Wilkins MR, Settle SL, Kirk JE, Taylor SA, Moore KP, Unwin RJ.
    Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
    [Abstract] [Full Text] [Related]

  • 18. Effects of physiological infusion of atrial natriuretic factor on healthy subjects and patients with the nephrotic syndrome.
    Woolf AS, Lyon TL, Hoffbrand BI, Cohen SL, Moult PJ.
    Nephron; 1989 Sep; 52(3):244-50. PubMed ID: 2544821
    [Abstract] [Full Text] [Related]

  • 19. Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome.
    Valentin JP, Qiu C, Muldowney WP, Ying WZ, Gardner DG, Humphreys MH.
    J Clin Invest; 1992 Oct; 90(4):1302-12. PubMed ID: 1328296
    [Abstract] [Full Text] [Related]

  • 20. Effect of atrial natriuretic peptide on blood pressure, guanosine 3':5'-cyclic monophosphate release and blood volume in uraemic patients.
    Jespersen B, Eiskjaer H, Pedersen EB.
    Clin Sci (Lond); 1990 Jan; 78(1):67-73. PubMed ID: 2153498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.